Stay updated on QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial page.

Latest updates to the QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange Detected- Revision label updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check26 days agoChange DetectedThe page shows a revision update from v3.4.2 to v3.4.3, with no changes to the study details.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision: v3.4.2 was added and the previous v3.4.1 funding notice was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check61 days agoChange DetectedA general government funding notice and a minor site revision (Revision: v3.4.1) were added; these changes do not affect study data, eligibility, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check68 days agoChange DetectedMinor textual updates: glossary display control added, capitalization changes to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and a new page revision tag 'v3.4.0' replacing 'v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded revision v3.3.4 and removed revision v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial page.